AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,884,000 | +369.1% | 257,855 | +127.5% | 0.01% | +400.0% |
| Q2 2020 | $1,894,000 | +367.7% | 113,365 | +303.4% | 0.00% | – |
| Q1 2020 | $405,000 | -68.8% | 28,100 | -27.5% | 0.00% | -100.0% |
| Q4 2019 | $1,299,000 | +464.8% | 38,783 | +253.6% | 0.00% | – |
| Q3 2019 | $230,000 | -55.8% | 10,967 | -42.5% | 0.00% | -100.0% |
| Q3 2018 | $520,000 | +145.3% | 19,072 | +141.4% | 0.00% | – |
| Q2 2018 | $212,000 | -60.2% | 7,900 | -52.8% | 0.00% | -100.0% |
| Q1 2018 | $533,000 | +111.5% | 16,741 | +68.4% | 0.00% | -50.0% |
| Q3 2015 | $252,000 | – | 9,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |